portefeuille (99.78)

biopharma investing

January 12, 2012 – Comments (3)

I have written quite a few posts on biopharma stocks. Apart from the linked stuff and the copies of parts of posts and "pitches" by zzlangerhans they contained little information. I still think providing more "original portefeuille" stuff is hardly useful as I am not all that entertaining and still not all that competent. I am doing alright trying to convert the stuff I read and listen to into "caps" game calls on stocks and virtual and less virtual trades and I might be approaching statistically significant effectiveness in "profitable biopharma investing" (in comparison to placebo in the form of the monkey with darts).

The usual obvious (to me) advantages of biopharma investing is that you get a little drama, somewhat interesting science and decent "financial return", but then again my drama and science preferences and my risk tolerance might not be that common.

Maybe scrolling through the stuff linked below can further support the idea that some money should be put into biopharma stocks ...

http://caps.fool.com/player/zzlangerhans/sectors.aspx?astable=biotechnology&filter=all#biotechnology.

http://caps.fool.com/player/portefeuille/sectors.aspx?astable=biotechnology&filter=all#biotechnology.

http://caps.fool.com/player/portefeuille2/sectors.aspx?astable=biotechnology&filter=all#biotechnology.

http://caps.fool.com/Blogs/ViewBlog.aspx?t=01007366137242330765.

http://caps.fool.com/Blogs/fund-trades/687712.